Literature DB >> 27941019

Incidence and predictors of sudden death, major conduction defects and sustained ventricular tachyarrhythmias in 1388 patients with myotonic dystrophy type 1.

Karim Wahbi1,2,3, Dominique Babuty4, Vincent Probst5, Ludivine Wissocque6, Fabien Labombarda7, Raphaël Porcher8, Henri Marc Bécane2, Arnaud Lazarus9, Anthony Béhin2, Pascal Laforêt2,10, Tanya Stojkovic2, Nicolas Clementy4, Aurélie Pattier Dussauge5,11, Jean Baptiste Gourraud5, Yann Pereon12, Arnaud Lacour13, Françoise Chapon14, Paul Milliez7, Didier Klug6, Bruno Eymard2,10, Denis Duboc1,2,3.   

Abstract

AIMS: To describe the incidence and identify predictors of sudden death (SD), major conduction defects and sustained ventricular tachyarrhythmias (VTA) in myotonic dystrophy type 1 (DM1). METHODS AND
RESULTS: We retrospectively enrolled 1388 adults with DM1 referred to six French medical centres between January 2000 and October 2013. We confirmed their vital status, classified all deaths, and determined the incidence of major conduction defects requiring permanent pacing and sustained VTA. We searched for predictors of overall survival, SD, major conduction defects, and sustained VTA by Cox regression analysis. Over a median 10-year follow-up, 253 (18.2%) patients died, 39 (3.6%) suddenly. Analysis of the cardiac rhythm at the time of the 39 SD revealed sustained VTA in 9, asystole in 5, complete atrioventricular block in 1 and electromechanical dissociation in two patients. Non-cardiac causes were identified in the five patients with SD who underwent autopsies. Major conduction defects developed in 143 (19.3%) and sustained VTA in 26 (2.3%) patients. By Cox regression analysis, age, family history of SD and left bundle branch block were independent predictors of SD, while age, male sex, electrocardiographic conduction abnormalities, syncope, and atrial fibrillation were independent predictors of major conduction defects; non-sustained VTA was the only predictor of sustained VTA.
CONCLUSIONS: SD was a frequent mode of death in DM1, with multiple mechanisms involved. Major conduction defects were by far more frequent than sustained VTA, whose only independent predictor was a personal history of non-sustained VTA. ClinicalTrials.gov no: NCT01136330. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Implantable cardioverter defibrillator; Myotonic dystrophy cardiomyopathy; Preventive pacing; Sudden cardiac death; Ventricular tachyarrhythmia; Ventricular tachycardia

Mesh:

Year:  2017        PMID: 27941019     DOI: 10.1093/eurheartj/ehw569

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  21 in total

1.  Non-invasive evaluation of the relationship between electrical and structural cardiac abnormalities in patients with myotonic dystrophy type 1.

Authors:  Lukas Chmielewski; Michael Bietenbeck; Alexandru Patrascu; Sabine Rösch; Udo Sechtem; Ali Yilmaz; Anca-Rezeda Florian
Journal:  Clin Res Cardiol       Date:  2019-02-14       Impact factor: 5.460

2.  A 34-year longitudinal study on long-term cardiac outcomes in DM1 patients with normal ECG at baseline at an Italian clinical centre.

Authors:  Elisabetta Bucci; Marco Testa; Loretta Licchelli; Alessandra Frattari; Nadia Attalla El Halabieh; Erica Gabriele; Giulia Pignatelli; Tiziana De Santis; Laura Fionda; Fiammetta Vanoli; Stefania Morino; Matteo Garibaldi; Antonella Di Pasquale; Nicola Vanacore; Annalisa Botta; Giovanni Antonini
Journal:  J Neurol       Date:  2018-02-10       Impact factor: 4.849

Review 3.  Dilated Cardiomyopathy: Genetic Determinants and Mechanisms.

Authors:  Elizabeth M McNally; Luisa Mestroni
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

4.  Survival patterns and cancer determinants in families with myotonic dystrophy type 1.

Authors:  A F Best; J E Hilbert; L Wood; W B Martens; N Nikolenko; C Marini-Bettolo; H Lochmüller; P S Rosenberg; R T Moxley; M H Greene; S M Gadalla
Journal:  Eur J Neurol       Date:  2018-09-16       Impact factor: 6.089

5.  Cardiac Manifestations of Myotonic Dystrophy in a Pediatric Cohort.

Authors:  Laia Brunet Garcia; Ankita Hajra; Ella Field; Joseph Wacher; Helen Walsh; Gabrielle Norrish; Adnan Manzur; Francesco Muntoni; Pinki Munot; Stephanie Robb; Rosaline Quinlivan; Mariacristina Scoto; Giovanni Baranello; Anna Sarkozy; Luke Starling; Juan Pablo Kaski; Elena Cervi
Journal:  Front Pediatr       Date:  2022-06-09       Impact factor: 3.569

6.  Predictors of respiratory decline in myotonic dystrophy type 1 (DM1): a longitudinal cohort study.

Authors:  Marco Mazzoli; Alessandra Ariatti; Giancarlo Garuti; Virginia Agnoletto; Riccardo Fantini; Alessandro Marchioni; Giuliana Galassi
Journal:  Acta Neurol Belg       Date:  2020-07-10       Impact factor: 2.396

7.  Twenty-four-hour ambulatory ECG monitoring relevancy in myotonic dystrophy type 1 follow-up: Prognostic value and heart rate variability evolution.

Authors:  Alexandre Gamet; Bruno Degand; François Le Gal; Nicolas Bidegain; Anne Delaubier; Brigitte Gilbert-Dussardier; Luc Christiaens; Rodrigue Garcia
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-08-12       Impact factor: 1.468

Review 8.  Syncope and the risk of sudden cardiac death: Evaluation, management, and prevention.

Authors:  Ryan J Koene; Wayne O Adkisson; David G Benditt
Journal:  J Arrhythm       Date:  2017-09-01

9.  Cardiac involvement in a cross-sectional cohort of myotonic dystrophies and other skeletal myopathies.

Authors:  Johannes Schmid; Meinrad Beer; Andrea Berghold; Tatjana Stojakovic; Hubert Scharnagl; Benjamin Dieplinger; Stefan Quasthoff; Josepha S Binder; Peter P Rainer
Journal:  ESC Heart Fail       Date:  2020-05-31

10.  CRISPR/Cas9-Mediated Deletion of CTG Expansions Recovers Normal Phenotype in Myogenic Cells Derived from Myotonic Dystrophy 1 Patients.

Authors:  Claudia Provenzano; Marisa Cappella; Rea Valaperta; Rosanna Cardani; Giovanni Meola; Fabio Martelli; Beatrice Cardinali; Germana Falcone
Journal:  Mol Ther Nucleic Acids       Date:  2017-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.